跳至主要内容
临床试验/JPRN-UMIN000009771
JPRN-UMIN000009771已完成未知

A Prospective Cohort Study on the Prediction of Effectiveness of Sorafenib on the Basis of Angiogenesis-Related Cytokines - The Prediction of Effectiveness of Sorafenib on the Basis of Angiogenesis-Related Cytokines

Okayama University Hospital0 个研究点目标入组 90 人开始时间: 2013年1月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with histologically confirmed mixed-type HCC or sarcomatous change 2) Patients with a history of molecular-targeted therapy 3) Patients with active double cancer (Patients who have early-stage cancer that does not appear to affect their prognosis and can be controlled by treatment may be enrolled in this study.) 4) Patients with any serious coexisting condition (e.g., ileus, interstitial pneumonia, pulmonary fibrosis, difficult-to-control diabetes mellitus, hypertension, cardiac failure, renal failure, hepatic failure, active peptic ulcer, varicose veins in danger of rupture, severe mental disorder or depression) 5) Patients with ascites and/or pleural effusion unresponsive to treatment 6) Patients judged by the principal investigator or subinvestigator to be unsuitable for participation for any other reason (to ensure the safe conduct of this study)

研究者

相似试验